fda semaglutide shortage lawsuit 🚨 A major just escalated pressure on compounded GLP-1s in Med Spas Last week, Novo Nordisk filed suit against telehealth company Hims & Hers over compounded products, signaling intensifying legal fda glp-1 shortage list lawsuit

"Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair." J Invest Dermatol

Nausea, vomiting and diarrhoea are predominantly included in this, alongside more serious changes in vision and pancreas inflammation

Whats more, some wellness and longevity clinics, as well as doctors offices, are skirting regulations and offering injectable GHK-Cu off-label for all-over aging, post-procedure wound healing, and in scalp treatments to address hair thinningbut again, the evidence for systemic use is scant and currently restricted

In contrast, more than 80% of those starting SGLT2 or insulin added another medication